Share price down over 10% on the back of announcing an NIH funded trial …. The market doesn’t believe we don’t need a CR (or cash injection via partnership/license deal) … simples
Ann: Mesoblast Partners with BMT CTN on Adult SR-aGVHD Trial, page-17
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
92.5¢ |
Change
-0.015(1.60%) |
Mkt cap ! $1.056B | |||
| Open | High | Low | Value | Volume |
| 95.0¢ | 95.0¢ | 92.5¢ | $709.2K | 762.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 24 | 210595 | 92.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 92.5¢ | 1321 | 7 |
View Market Depth
| Last trade - 11.09am 16/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |